Cargando…

Advances in Neurodegenerative Diseases

Detalles Bibliográficos
Autores principales:	Van Schependom, Jeroen, D’haeseleer, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002914/ https://www.ncbi.nlm.nih.gov/pubmed/36902495 http://dx.doi.org/10.3390/jcm12051709

Ejemplares similares

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
por: Van Schependom, Jeroen, et al.
Publicado: (2019)

Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
por: Van Schependom, Jeroen, et al.
Publicado: (2020)

Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis
por: Peeters, Gertjan, et al.
Publicado: (2023)

Feasibility of Real Time Internet-Based Teleconsultation in Patients With Multiple Sclerosis: Interventional Pilot Study
por: D'Haeseleer, Miguel, et al.
Publicado: (2020)

The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis
por: Akbarian, Fahimeh, et al.
Publicado: (2023)

Innovating Care in Multiple Sclerosis: Feasibility of Synchronous Internet-Based Teleconsultation for Longitudinal Clinical Monitoring
por: Sadeghi, Nima, et al.
Publicado: (2022)

Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
por: Sjøgård, Martin, et al.
Publicado: (2020)

Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial
por: Van Laethem, Delphine, et al.
Publicado: (2022)

The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis
por: Denissen, Stijn, et al.
Publicado: (2019)

Signal quality as Achilles’ heel of graph theory in functional magnetic resonance imaging in multiple sclerosis
por: Baijot, Johan, et al.
Publicado: (2021)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)

Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis
por: Baijot, Johan, et al.
Publicado: (2022)

Reliability of measuring regional callosal atrophy in neurodegenerative diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2016)

Spatiotemporal and spectral dynamics of multi‐item working memory as revealed by the n‐back task using MEG
por: Costers, Lars, et al.
Publicado: (2020)

The role of hippocampal theta oscillations in working memory impairment in multiple sclerosis
por: Costers, Lars, et al.
Publicado: (2020)

Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity
por: Temmerman, Joke, et al.
Publicado: (2022)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Microbial genotype–phenotype mapping by class association rule mining
por: Tamura, Makio, et al.
Publicado: (2008)

Increased brain atrophy and lesion load is associated with stronger lower alpha MEG power in multiple sclerosis patients
por: Van Schependom, Jeroen, et al.
Publicado: (2021)

Deciphering principles of transcription regulation in eukaryotic genomes
por: Nguyen, Dat H, et al.
Publicado: (2006)

Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis
por: Hostenbach, Stéphanie, et al.
Publicado: (2020)

The impact of menopause and hormone therapy on voice and nasal resonance
por: D’haeseleer, E., et al.
Publicado: (2012)

Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases
por: Bowerman, Melissa
Publicado: (2020)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Brain age as a surrogate marker for cognitive performance in multiple sclerosis
por: Denissen, Stijn, et al.
Publicado: (2022)

IDOL in metabolic, neurodegenerative and cardiovascular disease
por: van Loon, Nienke M., et al.
Publicado: (2018)

Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis
por: Wiels, Wietse A., et al.
Publicado: (2018)

Oxidative Stress in Neurodegenerative Diseases and Ageing
por: Pereira, Marcos D., et al.
Publicado: (2012)

Definition, prevalence and predictive factors of benign multiple sclerosis
por: Reynders, Tatjana, et al.
Publicado: (2017)

Protein Kinases and Neurodegenerative Diseases
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Protein Misfolding and Neurodegenerative Diseases
por: Cardinale, Alessio, et al.
Publicado: (2014)

Pain Assessment in Neurodegenerative Diseases
por: de Tommaso, Marina, et al.
Publicado: (2016)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Biochemical Biomarkers and Neurodegenerative Diseases
por: Ciaccio, Marcello
Publicado: (2021)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a8o05b34eqkit4jcm2tc3t3jn4